nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—ALB—focal segmental glomerulosclerosis	0.595	1	CbGaD
Sulindac—SLC22A6—Cyclosporine—focal segmental glomerulosclerosis	0.0634	1	CbGbCtD
Sulindac—MAPK3—nephron—focal segmental glomerulosclerosis	0.0295	0.26	CbGeAlD
Sulindac—MAPK3—endothelium—focal segmental glomerulosclerosis	0.0139	0.122	CbGeAlD
Sulindac—AKR1B1—nephron tubule—focal segmental glomerulosclerosis	0.00877	0.0773	CbGeAlD
Sulindac—AKR1B1—kidney—focal segmental glomerulosclerosis	0.00771	0.0679	CbGeAlD
Sulindac—PTGS2—nephron—focal segmental glomerulosclerosis	0.00765	0.0674	CbGeAlD
Sulindac—AKR1B1—cortex of kidney—focal segmental glomerulosclerosis	0.00751	0.0662	CbGeAlD
Sulindac—MAPK3—nephron tubule—focal segmental glomerulosclerosis	0.00636	0.056	CbGeAlD
Sulindac—MAPK3—kidney—focal segmental glomerulosclerosis	0.00559	0.0492	CbGeAlD
Sulindac—MAPK3—cortex of kidney—focal segmental glomerulosclerosis	0.00544	0.048	CbGeAlD
Sulindac—SLC22A6—nephron tubule—focal segmental glomerulosclerosis	0.00486	0.0429	CbGeAlD
Sulindac—SLC22A6—cortex of kidney—focal segmental glomerulosclerosis	0.00416	0.0367	CbGeAlD
Sulindac—PTGS1—endothelium—focal segmental glomerulosclerosis	0.00377	0.0332	CbGeAlD
Sulindac—PTGS2—endothelium—focal segmental glomerulosclerosis	0.00361	0.0318	CbGeAlD
Sulindac—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.0369	CcSEcCtD
Sulindac—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.00215	0.0325	CcSEcCtD
Sulindac—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.0268	CcSEcCtD
Sulindac—CYP1A1—kidney—focal segmental glomerulosclerosis	0.00173	0.0152	CbGeAlD
Sulindac—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.0259	CcSEcCtD
Sulindac—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.0242	CcSEcCtD
Sulindac—PTGS1—kidney—focal segmental glomerulosclerosis	0.00152	0.0134	CbGeAlD
Sulindac—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.0226	CcSEcCtD
Sulindac—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.0221	CcSEcCtD
Sulindac—PTGS2—kidney—focal segmental glomerulosclerosis	0.00145	0.0128	CbGeAlD
Sulindac—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.0202	CcSEcCtD
Sulindac—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.02	CcSEcCtD
Sulindac—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.0199	CcSEcCtD
Sulindac—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.0189	CcSEcCtD
Sulindac—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.0188	CcSEcCtD
Sulindac—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.0186	CcSEcCtD
Sulindac—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.0184	CcSEcCtD
Sulindac—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.0159	CcSEcCtD
Sulindac—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.0158	CcSEcCtD
Sulindac—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0152	CcSEcCtD
Sulindac—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.0152	CcSEcCtD
Sulindac—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.000996	0.0151	CcSEcCtD
Sulindac—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.000956	0.0145	CcSEcCtD
Sulindac—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000922	0.014	CcSEcCtD
Sulindac—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000917	0.0139	CcSEcCtD
Sulindac—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000909	0.0138	CcSEcCtD
Sulindac—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000896	0.0136	CcSEcCtD
Sulindac—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000893	0.0135	CcSEcCtD
Sulindac—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.000888	0.0135	CcSEcCtD
Sulindac—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000888	0.0135	CcSEcCtD
Sulindac—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000886	0.0134	CcSEcCtD
Sulindac—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000869	0.0132	CcSEcCtD
Sulindac—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00086	0.013	CcSEcCtD
Sulindac—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000818	0.0124	CcSEcCtD
Sulindac—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000788	0.0119	CcSEcCtD
Sulindac—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000763	0.0116	CcSEcCtD
Sulindac—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000759	0.0115	CcSEcCtD
Sulindac—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000734	0.0111	CcSEcCtD
Sulindac—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000731	0.0111	CcSEcCtD
Sulindac—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000723	0.011	CcSEcCtD
Sulindac—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000702	0.0106	CcSEcCtD
Sulindac—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000699	0.0106	CcSEcCtD
Sulindac—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000697	0.0106	CcSEcCtD
Sulindac—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000692	0.0105	CcSEcCtD
Sulindac—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000671	0.0102	CcSEcCtD
Sulindac—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000661	0.01	CcSEcCtD
Sulindac—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000658	0.00997	CcSEcCtD
Sulindac—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000651	0.00986	CcSEcCtD
Sulindac—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000642	0.00973	CcSEcCtD
Sulindac—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00064	0.00969	CcSEcCtD
Sulindac—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000638	0.00966	CcSEcCtD
Sulindac—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000617	0.00935	CcSEcCtD
Sulindac—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000615	0.00931	CcSEcCtD
Sulindac—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000606	0.00918	CcSEcCtD
Sulindac—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000606	0.00918	CcSEcCtD
Sulindac—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000606	0.00918	CcSEcCtD
Sulindac—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000599	0.00907	CcSEcCtD
Sulindac—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000581	0.0088	CcSEcCtD
Sulindac—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000581	0.0088	CcSEcCtD
Sulindac—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000569	0.00862	CcSEcCtD
Sulindac—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000562	0.00851	CcSEcCtD
Sulindac—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000554	0.00839	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00053	0.00802	CcSEcCtD
Sulindac—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000526	0.00796	CcSEcCtD
Sulindac—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000522	0.00791	CcSEcCtD
Sulindac—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000518	0.00785	CcSEcCtD
Sulindac—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000517	0.00783	CcSEcCtD
Sulindac—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000512	0.00775	CcSEcCtD
Sulindac—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000505	0.00765	CcSEcCtD
Sulindac—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000501	0.00759	CcSEcCtD
Sulindac—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000497	0.00753	CcSEcCtD
Sulindac—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000479	0.00726	CcSEcCtD
Sulindac—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000475	0.0072	CcSEcCtD
Sulindac—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000462	0.00699	CcSEcCtD
Sulindac—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00046	0.00696	CcSEcCtD
Sulindac—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000428	0.00649	CcSEcCtD
Sulindac—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000417	0.00632	CcSEcCtD
Sulindac—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000411	0.00623	CcSEcCtD
Sulindac—PTGDR2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000402	0.00248	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.0004	0.00246	CbGpPWpGaD
Sulindac—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000398	0.00602	CcSEcCtD
Sulindac—MAPK3—Syndecan-2-mediated signaling events—TGFB1—focal segmental glomerulosclerosis	0.000395	0.00244	CbGpPWpGaD
Sulindac—MAPK3—AGE/RAGE pathway—MMP2—focal segmental glomerulosclerosis	0.000393	0.00242	CbGpPWpGaD
Sulindac—CYP1A2—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000392	0.00242	CbGpPWpGaD
Sulindac—MAPK3—Toll-like Receptor Signaling Pathway—SPP1—focal segmental glomerulosclerosis	0.000392	0.00241	CbGpPWpGaD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—SERPINE1—focal segmental glomerulosclerosis	0.00039	0.0024	CbGpPWpGaD
Sulindac—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000384	0.00582	CcSEcCtD
Sulindac—PTGDR2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000383	0.00236	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.000381	0.00235	CbGpPWpGaD
Sulindac—MAPK3—Syndecan-1-mediated signaling events—TGFB1—focal segmental glomerulosclerosis	0.000378	0.00233	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000378	0.00233	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000371	0.00229	CbGpPWpGaD
Sulindac—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00037	0.0056	CcSEcCtD
Sulindac—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000367	0.00555	CcSEcCtD
Sulindac—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000366	0.00555	CcSEcCtD
Sulindac—PTGDR2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000365	0.00225	CbGpPWpGaD
Sulindac—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000364	0.00552	CcSEcCtD
Sulindac—AKR1B1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000363	0.00224	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000363	0.00224	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.000362	0.00223	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.000355	0.00219	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.000355	0.00219	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	0.000354	0.00218	CbGpPWpGaD
Sulindac—ALB—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000352	0.00217	CbGpPWpGaD
Sulindac—PPARD—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.000351	0.00217	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000347	0.00214	CbGpPWpGaD
Sulindac—MAPK3—FGF signaling pathway—MMP9—focal segmental glomerulosclerosis	0.000346	0.00214	CbGpPWpGaD
Sulindac—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000345	0.00523	CcSEcCtD
Sulindac—MAPK3—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.000338	0.00209	CbGpPWpGaD
Sulindac—MAPK3—Interleukin-11 Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000336	0.00207	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000336	0.00207	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000335	0.00207	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000335	0.00206	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.000326	0.00201	CbGpPWpGaD
Sulindac—MAPK3—IL-3 Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000309	0.0019	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000307	0.0019	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—SPP1—focal segmental glomerulosclerosis	0.000306	0.00188	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000305	0.00188	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.000303	0.00187	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.000299	0.00185	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—SPP1—focal segmental glomerulosclerosis	0.000297	0.00183	CbGpPWpGaD
Sulindac—CYP1A1—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.000296	0.00183	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	0.000296	0.00183	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000295	0.00182	CbGpPWpGaD
Sulindac—MAPK3—AGE/RAGE pathway—MMP9—focal segmental glomerulosclerosis	0.000295	0.00182	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000293	0.00181	CbGpPWpGaD
Sulindac—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.00029	0.00179	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.000287	0.00177	CbGpPWpGaD
Sulindac—MAPK3—TGF-beta Receptor Signaling—TGFB1—focal segmental glomerulosclerosis	0.000286	0.00176	CbGpPWpGaD
Sulindac—MAPK3—Cardiac Hypertrophic Response—TGFB1—focal segmental glomerulosclerosis	0.000281	0.00173	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000279	0.00172	CbGpPWpGaD
Sulindac—PPARD—Adipogenesis—TGFB1—focal segmental glomerulosclerosis	0.000277	0.00171	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.000277	0.00171	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000274	0.00169	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.000263	0.00162	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.000261	0.00161	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000261	0.00161	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.000255	0.00157	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.000253	0.00156	CbGpPWpGaD
Sulindac—PPARD—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	0.000252	0.00156	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—LPL—focal segmental glomerulosclerosis	0.000252	0.00155	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—SPP1—focal segmental glomerulosclerosis	0.000246	0.00152	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000241	0.00149	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—FN1—focal segmental glomerulosclerosis	0.000241	0.00149	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Telomerase—TGFB1—focal segmental glomerulosclerosis	0.000237	0.00146	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000237	0.00146	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.000235	0.00145	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000233	0.00143	CbGpPWpGaD
Sulindac—PTGS1—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000229	0.00141	CbGpPWpGaD
Sulindac—PTGS1—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.000229	0.00141	CbGpPWpGaD
Sulindac—ALB—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.000228	0.0014	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000216	0.00133	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000216	0.00133	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—AGT—focal segmental glomerulosclerosis	0.000215	0.00133	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000214	0.00132	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.000213	0.00131	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000205	0.00126	CbGpPWpGaD
Sulindac—MAPK3—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—focal segmental glomerulosclerosis	0.000201	0.00124	CbGpPWpGaD
Sulindac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.0002	0.00123	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000196	0.00121	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.000195	0.0012	CbGpPWpGaD
Sulindac—ALB—Platelet degranulation—FN1—focal segmental glomerulosclerosis	0.000191	0.00118	CbGpPWpGaD
Sulindac—MAPK3—TCR Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.00019	0.00117	CbGpPWpGaD
Sulindac—MAPK3—Corticotropin-releasing hormone—TGFB1—focal segmental glomerulosclerosis	0.000186	0.00115	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.000186	0.00115	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	0.000185	0.00114	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.000185	0.00114	CbGpPWpGaD
Sulindac—ALB—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.000183	0.00113	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.000183	0.00113	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000182	0.00112	CbGpPWpGaD
Sulindac—ALB—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	0.000182	0.00112	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.000182	0.00112	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00018	0.00111	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.000176	0.00109	CbGpPWpGaD
Sulindac—CYP1A1—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	0.000176	0.00108	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000175	0.00108	CbGpPWpGaD
Sulindac—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	0.000172	0.00106	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000171	0.00106	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.000171	0.00105	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	0.00017	0.00105	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.000169	0.00104	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000168	0.00103	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—ALB—focal segmental glomerulosclerosis	0.000165	0.00102	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000165	0.00102	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—MMP9—focal segmental glomerulosclerosis	0.000161	0.000991	CbGpPWpGaD
Sulindac—PPARD—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.00016	0.000988	CbGpPWpGaD
Sulindac—ALB—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	0.000159	0.00098	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	0.000153	0.000942	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000153	0.000941	CbGpPWpGaD
Sulindac—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	0.000151	0.000933	CbGpPWpGaD
Sulindac—PPARD—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000149	0.000921	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000147	0.000908	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.000146	0.000903	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000146	0.000902	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.000146	0.000902	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	0.000142	0.000878	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00014	0.000862	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000138	0.000853	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000136	0.000836	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000134	0.000829	CbGpPWpGaD
Sulindac—PPARD—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000132	0.000811	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000128	0.000792	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000128	0.000791	CbGpPWpGaD
Sulindac—MAPK3—Immune System—MYH9—focal segmental glomerulosclerosis	0.000124	0.000766	CbGpPWpGaD
Sulindac—ALB—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.000123	0.000756	CbGpPWpGaD
Sulindac—PPARD—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000121	0.000747	CbGpPWpGaD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000119	0.000733	CbGpPWpGaD
Sulindac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.000119	0.000731	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000117	0.000722	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000116	0.000715	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000115	0.00071	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000113	0.000696	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—PCNA—focal segmental glomerulosclerosis	0.000113	0.000695	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	0.00011	0.00068	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00011	0.000678	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000109	0.000674	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000108	0.000668	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000107	0.000661	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000105	0.000646	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000104	0.000642	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000104	0.000641	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000102	0.000628	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—PCNA—focal segmental glomerulosclerosis	0.000101	0.000621	CbGpPWpGaD
Sulindac—ALB—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	0.0001	0.000619	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	9.96e-05	0.000614	CbGpPWpGaD
Sulindac—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	9.56e-05	0.000589	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	9.25e-05	0.00057	CbGpPWpGaD
Sulindac—PPARD—Metabolism—LPL—focal segmental glomerulosclerosis	9.12e-05	0.000562	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	9.09e-05	0.00056	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—FN1—focal segmental glomerulosclerosis	9.07e-05	0.00056	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	9.04e-05	0.000557	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—NOS2—focal segmental glomerulosclerosis	8.97e-05	0.000553	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	8.97e-05	0.000553	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.92e-05	0.00055	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TRPC6—focal segmental glomerulosclerosis	8.78e-05	0.000542	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	8.76e-05	0.00054	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—CTGF—focal segmental glomerulosclerosis	8.64e-05	0.000532	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	8.47e-05	0.000522	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	8.42e-05	0.000519	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—MMP9—focal segmental glomerulosclerosis	8.26e-05	0.000509	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	8.24e-05	0.000508	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	8.01e-05	0.000494	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	7.96e-05	0.000491	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—MMP2—focal segmental glomerulosclerosis	7.84e-05	0.000484	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	7.83e-05	0.000483	CbGpPWpGaD
Sulindac—PPARD—Metabolism—AGT—focal segmental glomerulosclerosis	7.8e-05	0.000481	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	7.71e-05	0.000475	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	7.6e-05	0.000469	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	7.55e-05	0.000466	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—ALB—focal segmental glomerulosclerosis	7.54e-05	0.000465	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD79A—focal segmental glomerulosclerosis	7.52e-05	0.000464	CbGpPWpGaD
Sulindac—ALB—Hemostasis—GNAQ—focal segmental glomerulosclerosis	7.34e-05	0.000453	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	7.25e-05	0.000447	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	7.05e-05	0.000435	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.83e-05	0.000421	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	6.79e-05	0.000419	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	6.7e-05	0.000413	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	6.22e-05	0.000383	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.19e-05	0.000382	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	6.18e-05	0.000381	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.15e-05	0.000379	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD40LG—focal segmental glomerulosclerosis	6.13e-05	0.000378	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	6.04e-05	0.000372	CbGpPWpGaD
Sulindac—PPARD—Metabolism—ALB—focal segmental glomerulosclerosis	5.98e-05	0.000369	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—MMP9—focal segmental glomerulosclerosis	5.9e-05	0.000364	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	5.76e-05	0.000355	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—LIPC—focal segmental glomerulosclerosis	5.71e-05	0.000352	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.64e-05	0.000348	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.63e-05	0.000347	CbGpPWpGaD
Sulindac—MAPK3—Disease—LPL—focal segmental glomerulosclerosis	5.56e-05	0.000343	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.52e-05	0.00034	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.32e-05	0.000328	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.17e-05	0.000319	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	5.14e-05	0.000317	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	5.07e-05	0.000313	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CTGF—focal segmental glomerulosclerosis	5.03e-05	0.00031	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.03e-05	0.00031	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	4.86e-05	0.0003	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TGFB1—focal segmental glomerulosclerosis	4.77e-05	0.000294	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.73e-05	0.000292	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.72e-05	0.000291	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.63e-05	0.000286	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—LIPC—focal segmental glomerulosclerosis	4.54e-05	0.00028	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	4.45e-05	0.000274	CbGpPWpGaD
Sulindac—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	4.37e-05	0.000269	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOS2—focal segmental glomerulosclerosis	4.34e-05	0.000268	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	4.31e-05	0.000266	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.3e-05	0.000265	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.08e-05	0.000252	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—LIPC—focal segmental glomerulosclerosis	4.03e-05	0.000248	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.01e-05	0.000247	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CTGF—focal segmental glomerulosclerosis	3.99e-05	0.000246	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	3.94e-05	0.000243	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.89e-05	0.00024	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.69e-05	0.000227	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.68e-05	0.000227	CbGpPWpGaD
Sulindac—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	3.67e-05	0.000226	CbGpPWpGaD
Sulindac—MAPK3—Disease—SERPINE1—focal segmental glomerulosclerosis	3.66e-05	0.000225	CbGpPWpGaD
Sulindac—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	3.63e-05	0.000224	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.62e-05	0.000223	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CTGF—focal segmental glomerulosclerosis	3.54e-05	0.000219	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.52e-05	0.000217	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	3.49e-05	0.000215	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.33e-05	0.000205	CbGpPWpGaD
Sulindac—PTGS2—Disease—LPL—focal segmental glomerulosclerosis	3.31e-05	0.000204	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.27e-05	0.000201	CbGpPWpGaD
Sulindac—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	3.23e-05	0.000199	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.08e-05	0.00019	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.01e-05	0.000186	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	2.98e-05	0.000184	CbGpPWpGaD
Sulindac—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.98e-05	0.000184	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—LPL—focal segmental glomerulosclerosis	2.77e-05	0.000171	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS2—focal segmental glomerulosclerosis	2.58e-05	0.000159	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	2.57e-05	0.000158	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.56e-05	0.000158	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—LPL—focal segmental glomerulosclerosis	2.46e-05	0.000151	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—AGT—focal segmental glomerulosclerosis	2.37e-05	0.000146	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.31e-05	0.000142	CbGpPWpGaD
Sulindac—MAPK3—Disease—TGFB1—focal segmental glomerulosclerosis	2.31e-05	0.000142	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	2.29e-05	0.000141	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	2.29e-05	0.000141	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	2.26e-05	0.000139	CbGpPWpGaD
Sulindac—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	2.24e-05	0.000138	CbGpPWpGaD
Sulindac—PTGS2—Disease—SERPINE1—focal segmental glomerulosclerosis	2.17e-05	0.000134	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—AGT—focal segmental glomerulosclerosis	2.1e-05	0.00013	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.08e-05	0.000128	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.96e-05	0.000121	CbGpPWpGaD
Sulindac—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	1.92e-05	0.000118	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ALB—focal segmental glomerulosclerosis	1.82e-05	0.000112	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.62e-05	9.96e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ALB—focal segmental glomerulosclerosis	1.61e-05	9.94e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	1.57e-05	9.66e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—TGFB1—focal segmental glomerulosclerosis	1.37e-05	8.46e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	1.34e-05	8.26e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	1.03e-05	6.34e-05	CbGpPWpGaD
